These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19428574)

  • 1. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution.
    de Moura WC; de Araujo HP; Cabello PH; Romijn PC; Leite JP
    J Virol Methods; 2009 Jun; 158(1-2):84-92. PubMed ID: 19428574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a virus neutralization potency test in BHK-21 cells for rabies immunoglobulins in a two-center study.
    de Moura WC; Gallina NM; Fuches RM; Romijn PC; Leite JP
    J Virol Methods; 2008 Dec; 154(1-2):7-13. PubMed ID: 18851992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity.
    Tint H; Rosanoff EI
    Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach.
    Akkermans AM; Hendriksen CF
    Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution - Part 2.
    Machado NS; Moreira WC; Freitas JFS; Almeida AECC; Moura WC
    Biologicals; 2020 Jul; 66():30-34. PubMed ID: 32448736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of inactivated rabies vaccine for human use on WI38 diploid cells. Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms.
    Nicolas AJ; Patet J; Falquet JC; Branche R; Delaiti P; Montagnon B; Peyron L; Soulebot JP
    Dev Biol Stand; 1978; 40():17-24. PubMed ID: 680392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the usefulness of the peripheral test for determination of rabies vaccine potency].
    Wysokińska T; Janaszek W; Rymkiewicz D; Słowikowska M
    Med Dosw Mikrobiol; 1996; 48(3-4):211-3. PubMed ID: 9182144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NIH potency tests with inactivated rabies vaccines (author's transl)].
    Barth R; Jaeger O
    Zentralbl Bakteriol B; 1979; 169(5-6):488-94. PubMed ID: 545949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory investigations on neuroparalytic accidents associated with suckling mouse brain rabies vaccine. III. -- Preservation of vaccine potency after elimination of murine brain myelin by centrifugation.
    Larghi OP; Varela-Diaz VM; Soto E; Imas B; Cuba-Caparo A; Fuenzalida E
    Ann Microbiol (Paris); 1976; 127B(4):567-72. PubMed ID: 1023791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thermostability of rabies vaccine, type Fuenzalida & Palacios, for human use].
    Albas A; Fuches RM; Gallina NM; Mendonça RM; Fang FL; Valentini EJ
    Rev Inst Med Trop Sao Paulo; 1992; 34(1):27-31. PubMed ID: 1284895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Time and Cost Benefit Antibody Binding Test-Based Method for Determination of Rabies Vaccine Potency.
    Asgary V; Mojtabavi N; Janani A; Mousavi T; Hadjati J; Khosravy MS; Ahangari Cohan R
    Viral Immunol; 2017 Apr; 30(3):204-209. PubMed ID: 28118120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.